Literature DB >> 32220311

Curing HIV: Seeking to Target and Clear Persistent Infection.

David M Margolis1, Nancie M Archin2, Myron S Cohen3, Joseph J Eron2, Guido Ferrari4, J Victor Garcia5, Cynthia L Gay2, Nilu Goonetilleke6, Sarah B Joseph7, Ronald Swanstrom8, Anne-Marie W Turner2, Angela Wahl5.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) infection persists despite years of antiretroviral therapy (ART). To remove the stigma and burden of chronic infection, approaches to eradicate or cure HIV infection are desired. Attempts to augment ART with therapies that reverse viral latency, paired with immunotherapies to clear infection, have advanced into the clinic, but the field is still in its infancy. We review foundational studies and highlight new insights in HIV cure research. Together with advances in ART delivery and HIV prevention strategies, future therapies that clear HIV infection may relieve society of the affliction of the HIV pandemic.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32220311      PMCID: PMC7896558          DOI: 10.1016/j.cell.2020.03.005

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  149 in total

1.  Expanded cytotoxic T-cell lymphocytes target the latent HIV reservoir.

Authors:  Julia A Sung; Sharon Lam; Carolina Garrido; Nancie Archin; Cliona M Rooney; Catherine M Bollard; David M Margolis
Journal:  J Infect Dis       Date:  2015-01-13       Impact factor: 5.226

2.  OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion.

Authors:  R M van Praag; J M Prins; M T Roos; P T Schellekens; I J Ten Berge; S L Yong; H Schuitemaker; A J Eerenberg; S Jurriaans; F de Wolf; C H Fox; J Goudsmit; F Miedema; J M Lange
Journal:  J Clin Immunol       Date:  2001-05       Impact factor: 8.317

3.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Authors:  T W Chun; L Stuyver; S B Mizell; L A Ehler; J A Mican; M Baseler; A L Lloyd; M A Nowak; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

4.  Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy.

Authors:  Carolina Gutiérrez; Sergio Serrano-Villar; Nadia Madrid-Elena; Maria J Pérez-Elías; Maria Elena Martín; Coral Barbas; Javier Ruipérez; Eduardo Muñoz; Maria Angeles Muñoz-Fernández; Trevor Castor; Santiago Moreno
Journal:  AIDS       Date:  2016-06-01       Impact factor: 4.177

5.  Viremic relapse after HIV-1 remission in a perinatally infected child.

Authors:  Katherine Luzuriaga; Hannah Gay; Carrie Ziemniak; Keri B Sanborn; Mohan Somasundaran; Kaitlin Rainwater-Lovett; John W Mellors; Daniel Rosenbloom; Deborah Persaud
Journal:  N Engl J Med       Date:  2015-02-19       Impact factor: 91.245

6.  The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation.

Authors:  Melissa-Rose Abrahams; Sarah B Joseph; Nigel Garrett; Lynn Tyers; Matthew Moeser; Nancie Archin; Olivia D Council; David Matten; Shuntai Zhou; Deelan Doolabh; Colin Anthony; Nilu Goonetilleke; Salim Abdool Karim; David M Margolis; Sergei Kosakovsky Pond; Carolyn Williamson; Ronald Swanstrom
Journal:  Sci Transl Med       Date:  2019-10-09       Impact factor: 17.956

Review 7.  Envelope-specific antibodies and antibody-derived molecules for treating and curing HIV infection.

Authors:  Guido Ferrari; Barton F Haynes; Scott Koenig; Jeffrey L Nordstrom; David M Margolis; Georgia D Tomaras
Journal:  Nat Rev Drug Discov       Date:  2016-10-07       Impact factor: 84.694

8.  Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.

Authors:  J K Wong; M Hezareh; H F Günthard; D V Havlir; C C Ignacio; C A Spina; D D Richman
Journal:  Science       Date:  1997-11-14       Impact factor: 47.728

9.  Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.

Authors:  Pablo Tebas; David Stein; Winson W Tang; Ian Frank; Shelley Q Wang; Gary Lee; S Kaye Spratt; Richard T Surosky; Martin A Giedlin; Geoff Nichol; Michael C Holmes; Philip D Gregory; Dale G Ando; Michael Kalos; Ronald G Collman; Gwendolyn Binder-Scholl; Gabriela Plesa; Wei-Ting Hwang; Bruce L Levine; Carl H June
Journal:  N Engl J Med       Date:  2014-03-06       Impact factor: 91.245

10.  HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected Individuals.

Authors:  Julia A Sung; Shabnum Patel; Matthew L Clohosey; Lauren Roesch; Tamara Tripic; JoAnn D Kuruc; Nancie Archin; Patrick J Hanley; C Russell Cruz; Nilu Goonetilleke; Joseph J Eron; Clio M Rooney; Cynthia L Gay; Catherine M Bollard; David M Margolis
Journal:  Mol Ther       Date:  2018-09-21       Impact factor: 11.454

View more
  38 in total

1.  Longitudinal Dynamics of Intact HIV Proviral DNA and Outgrowth Virus Frequencies in a Cohort of Individuals Receiving Antiretroviral Therapy.

Authors:  Shane D Falcinelli; Kayla W Kilpatrick; Jenna Read; Ross Murtagh; Brigitte Allard; Simon Ghofrani; Jennifer Kirchherr; Katherine S James; Erin Stuelke; Caroline Baker; JoAnn D Kuruc; Joseph J Eron; Michael G Hudgens; Cynthia L Gay; David M Margolis; Nancie M Archin
Journal:  J Infect Dis       Date:  2021-07-02       Impact factor: 5.226

2.  Evaluation of HIV-1 latency reversal and antibody-dependent viral clearance by quantification of singly spliced HIV-1 vpu/env mRNA.

Authors:  Hongbo Gao; Ayşe N Ozantürk; Qiankun Wang; Gray H Harlan; Aaron J Schmitz; Rachel M Presti; Kai Deng; Liang Shan
Journal:  J Virol       Date:  2021-03-24       Impact factor: 5.103

Review 3.  Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021.

Authors:  Steven G Deeks; Nancie Archin; Paula Cannon; Simon Collins; R Brad Jones; Marein A W P de Jong; Olivier Lambotte; Rosanne Lamplough; Thumbi Ndung'u; Jeremy Sugarman; Caroline T Tiemessen; Linos Vandekerckhove; Sharon R Lewin
Journal:  Nat Med       Date:  2021-12-01       Impact factor: 53.440

Review 4.  An ordeal that does not heal: understanding barriers to a cure for HIV-1 infection.

Authors:  Mathias Lichterfeld; Ce Gao; Xu G Yu
Journal:  Trends Immunol       Date:  2022-08       Impact factor: 19.709

5.  Combination anti-HIV antibodies provide sustained virological suppression.

Authors:  Michael C Sneller; Jana Blazkova; Susan Moir; Tae-Wook Chun; J Shawn Justement; Victoria Shi; Brooke D Kennedy; Kathleen Gittens; Jekaterina Tolstenko; Genevieve McCormack; Emily J Whitehead; Rachel F Schneck; Michael A Proschan; Erika Benko; Colin Kovacs; Cihan Oguz; Michael S Seaman; Marina Caskey; Michel C Nussenzweig; Anthony S Fauci
Journal:  Nature       Date:  2022-06-01       Impact factor: 69.504

6.  An Update on Antiretroviral Therapy.

Authors:  Luis Menéndez-Arias; Samara Martín-Alonso; Estrella Frutos-Beltrán
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  SMAC Mimetic Plus Triple-Combination Bispecific HIVxCD3 Retargeting Molecules in SHIV.C.CH505-Infected, Antiretroviral Therapy-Suppressed Rhesus Macaques.

Authors:  Amir Dashti; Chevaughn Waller; Maud Mavigner; Nils Schoof; Katharine J Bar; George M Shaw; Thomas H Vanderford; Shan Liang; Jeffrey D Lifson; Richard M Dunham; Guido Ferrari; Marina Tuyishime; Chia-Ying K Lam; Jeffrey L Nordstrom; David M Margolis; Guido Silvestri; Ann Chahroudi
Journal:  J Virol       Date:  2020-10-14       Impact factor: 5.103

Review 8.  So Pathogenic or So What?-A Brief Overview of SIV Pathogenesis with an Emphasis on Cure Research.

Authors:  Adam J Kleinman; Ivona Pandrea; Cristian Apetrei
Journal:  Viruses       Date:  2022-01-12       Impact factor: 5.048

Review 9.  The Contributions of Clinical Pharmacology to HIV Cure Research.

Authors:  Courtney V Fletcher; Shetty Ravi Dyavar; Arpan Acharya; Siddappa N Byrareddy
Journal:  Clin Pharmacol Ther       Date:  2021-04-18       Impact factor: 6.903

Review 10.  Addressing an HIV cure in LMIC.

Authors:  Sherazaan D Ismail; Joshua Pankrac; Emmanuel Ndashimye; Jessica L Prodger; Melissa-Rose Abrahams; Jamie F S Mann; Andrew D Redd; Eric J Arts
Journal:  Retrovirology       Date:  2021-08-03       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.